Medicare Enrolled

Dr. Stavros Moysidis, M.D.

Ophthalmology · Encino, CA
Practice pattern: Mixed Practice — Diverse clinical practice across multiple procedure types
Low-engagement
5400 BALBOA BLVD STE 126, Encino, CA 91316
8185780004
In practice since 2013 (12 years)
NPI: 1780023929 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Moysidis from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Moysidis? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Moysidis

Dr. Stavros Moysidis is an ophthalmology specialist in Encino, CA, with 12 years of NPI registration. Based on federal Medicare data, Dr. Moysidis performed 6,821 Medicare services across 1,371 unique beneficiaries.

Between the years covered by Open Payments, Dr. Moysidis received a total of $4,594 from 25 pharmaceutical and/or device companies across 95 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in ophthalmology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Moysidis is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 12 years in practice ▲ Top 14% volume in CA $4,594 industry payments

Medicare Practice Summary

Medicare Utilization ↗
6,821
Medicare services
Top 14% in CA for ophthalmology
1,371
Unique beneficiaries
$50
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~568 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Eye injection (Vabysmo/faricimab)
An injection of faricimab-svoa, a medication administered in 0.1 mg doses.
3,901 $29 $45
Retinal imaging (OCT scan)
This procedure involves imaging the retina to visualize its structure. It is used to examine the back of the eye.
1,123 $35 $134
Comprehensive eye exam, established patient
A comprehensive examination of the visual system performed for a patient who has previously been seen by the provider.
739 $106 $172
Eye injection for retinal disease
A procedure involving the administration of medication directly into the eye.
415 $119 $334
Compounded drug, not otherwise classified
A medication prepared specifically for an individual patient by a pharmacist or physician, tailored to meet unique needs that cannot be fulfilled by commercially available products.
359 $73 $119
New patient office visit (45-59 min)
An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter.
94 $139 $237
Eye exam, established patient, focused
A limited examination of the visual system for an existing patient. The provider focuses on a specific eye-related concern or symptom.
62 $81 $125
Ultrasound of eye tissue and structures
A diagnostic imaging test that uses sound waves to create pictures of the eye's internal tissues and structures.
28 $34 $136
Retinal photography (fundus photo)
This procedure involves taking photographs of the retina, the light-sensitive tissue at the back of the eye. It is used to document the condition of the eye's interior structures.
23 $34 $100
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
21 $91 $174
Extended exam of back of eye with optic nerve drawing
A detailed examination of the posterior section of the eye, including the optic nerve, with documentation through drawing.
19 $14 $80
Vitreous removal between lens and retina
This procedure involves the removal of the vitreous fluid located between the lens and the retina of the eye.
13 $790 $2,615
Comprehensive eye exam, new patient
A comprehensive examination of the visual system performed for a new patient.
12 $119 $224
Visual field test, extended
A test that maps your complete field of vision to detect blind spots or peripheral vision loss. Extended testing provides a more detailed assessment than a standard visual field exam.
12 $53 $150
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$4,594
Total received (2018-2024)
Avg $656/year across 7 years
Top 26% in CA for ophthalmology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
25
Companies
95
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$4,594 (100.0%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$572
2023
$237
2022
$445
2021
$436
2020
$266
2019
$1,055
2018
$1,584

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Apellis Pharmaceuticals, Inc.
$218
ABBVIE INC.
$94
Genentech USA, Inc.
$80
Alimera Sciences, Inc.
$64
Astellas Pharma US Inc
$55
Regeneron Healthcare Solutions, Inc.
$38
Optos, Inc.
$22
Top 3 companies account for 68.6% of 2024 payments
All-time payments by company (2018-2024) ›
Regeneron Healthcare Solutions, Inc.
$1,296
Regeneron Pharmaceuticals, Inc.
$813
Genentech USA, Inc.
$541
Apellis Pharmaceuticals, Inc.
$247
Novartis Pharmaceuticals Corporation
$217
Alcon Vision LLC
$186
Alimera Sciences, Inc.
$184
ABBVIE INC.
$135
Aerie Pharmaceuticals, Inc.
$125
Alcon Laboratories Inc
$125
AbbVie, Inc.
$118
Genentech, Inc.
$111
Johnson & Johnson Surgical Vision, Inc.
$107
Astellas Pharma US Inc
$74
Allergan, Inc.
$59
OPTOS, INC.
$42
EyePoint Pharmaceuticals US, Inc.
$39
Carl Zeiss Meditec AG
$39
Thea Pharma Inc.
$24
Optos, Inc.
$22
Bausch & Lomb Americas Inc.
$22
Allergan Inc.
$21
Bausch & Lomb, a division of Bausch Health US, LLC
$19
Spark Therapeutics, Inc.
$16
Dutch Ophthalmic, USA
$15
Top 3 companies account for 57.7% of all-time payments
Associated products mentioned in payments ›
ARGOS · Constellation · DEXYCU · EVA Ophthalmic Surgical System · EYLEA · EYLEA AFLIBERCEPT INJECTION · EYLEA HD · Humira · ILUVIEN · IYUZEH · Iluvien · Izervay · LUMIGAN · LUXTURNA · Lucentis · NFC-700 · None Specified · OZURDEX · P200DTx · RETISERT · Rhopressa · Syfovre · Tecnis Symfony IOL · Vabysmo · XIPERE · YUTIQ
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.

Looking for an ophthalmology specialist in Encino?
Compare ophthalmologists in the Encino area by procedure volume, costs, and industry payment transparency.
Browse ophthalmologists nearby

Geographic Context

Ophthalmologists within 10 mi
629
Per 100K population
6.4
County median income
$87,760
Nearest hospital
ENCINO HOSPITAL MEDICAL CENTER
1.7 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Moysidis is a mixed practice specialist, with above-average Medicare volume (top 14% in CA), with low-engagement industry engagement.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Moysidis experienced with eye injection (vabysmo/faricimab)?
Based on Medicare claims data, Dr. Moysidis performed 3,901 eye injection (vabysmo/faricimab) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Moysidis receive payments from pharmaceutical companies?
Yes. Dr. Moysidis received a total of $4,594 from 25 companies across 95 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Moysidis's costs compare to other ophthalmologists in Encino?
Dr. Moysidis's average Medicare payment per service is $50. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Moysidis) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →